Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Sells $25,875,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 2,250,000 shares of the firm’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $11.50, for a total transaction of $25,875,000.00. Following the completion of the transaction, the insider directly owned 12,315,892 shares of the company’s stock, valued at approximately $141,632,758. This trade represents a 15.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Aveanna Healthcare Price Performance

Aveanna Healthcare stock opened at $13.62 on Thursday. The company has a market cap of $2.97 billion, a price-to-earnings ratio of 11.07, a PEG ratio of 0.85 and a beta of 1.90. The firm’s fifty day moving average is $9.95 and its 200 day moving average is $8.03. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. Aveanna Healthcare Holdings Inc. has a 52-week low of $5.93 and a 52-week high of $13.98.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The business had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. Sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Aveanna Healthcare during the second quarter valued at approximately $270,000. California State Teachers Retirement System lifted its stake in shares of Aveanna Healthcare by 1,351.3% during the 2nd quarter. California State Teachers Retirement System now owns 730,027 shares of the company’s stock worth $6,256,000 after acquiring an additional 679,727 shares during the last quarter. Braidwell LP boosted its holdings in Aveanna Healthcare by 39.1% during the 2nd quarter. Braidwell LP now owns 3,065,106 shares of the company’s stock valued at $26,268,000 after acquiring an additional 861,600 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Aveanna Healthcare by 17.6% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 96,956 shares of the company’s stock valued at $831,000 after acquiring an additional 14,492 shares during the period. Finally, Littlejohn & Co. LLC bought a new position in Aveanna Healthcare in the 2nd quarter valued at $1,846,878,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on AVAH shares. Raymond James Financial boosted their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research note on Friday, August 14th. Truist Financial raised their price objective on Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a research note on Monday. Wall Street Zen cut Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. BMO Capital Markets boosted their target price on Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Finally, Royal Bank Of Canada raised their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $12.89.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.